Similar Items: Use of Rituximab for Dermatomyositis Over Conventional Therapy: A Case Report
- Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome
- Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
- Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
- Clinical Images: Skin manifestations and radiographic findings of anti‐SAE1 positive dermatomyositis
- Correction to: OA20 A case of rapidly progressive interstitial lung disease in anti-Ro52 positive amyopathic dermatomyositis
- Clinically Amyopathic Dermatomyositis: Epidemiology, Clinical Presentation, Pathophysiology, Treatment, and Prognosis: A Systematic Review